Skip to content

Different infusion of propofol combined with alfentanil for pediatric shared airway surgery-a randomized controlled trial

Different infusion of propofol combined with alfentanil for pediatric shared airway surgery-a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074066
Enrollment
Unknown
Registered
2023-07-28
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway abnormalities

Interventions

TCI group:TCI propofol infusion
MAN group:MAN propofol infusion

Sponsors

Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 10 Years

Inclusion criteria

Inclusion criteria: 1. Aged 2 to 10 years; 2. No gender limit; 3. Patients with airway abnormalities required direct laryngobronchoscopy or surgery; 4. ASA II ~ III; 5. Signing informed consent.

Exclusion criteria

Exclusion criteria: 2. The patient had a history of allergy to the experimental drug; 4. The patient was complicated with arrhythmia; 5. The patient was complicated with epilepsy; 6. The patients and their guardians declined to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Maximum arterial carbon dioxide;

Secondary

MeasureTime frame
incidence of apnea;Incidence of hypoxemia;Incidence of coughing;Incidence of laryngeal spasms ;Dose of propofol;Vital signs;Length of stay at the PACU;

Countries

China

Contacts

Public ContactZhang Ruidong

Shanghai Children's Medical Center, Shanghai Jiaotong University School of Medicine

doctorruidong@163.com+86 189 1663 7626

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026